Advocacy intelligence hub — real-time data for patient organizations
Ultragenyx Pharmaceutical Inc — PHASE3
Ultragenyx Pharmaceutical Inc
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all 3-hydroxyacyl-CoA dehydrogenase deficiency news →
Nicholas Ah Mew, MD
Children's National Research Institute
Maciej Gawęcki
phthalmology of Pomeranian Hospitals in Wejherowo
Hak Chung
Oregon Health and Science University
Ashley Gregor
Oregon Health & Science University
Ken K Nischal
University of Pittsburgh School of Medicine
Magdalena Hubert
phthalmology of Pomeranian Hospitals in Wejherowo
View all 3-hydroxyacyl-CoA dehydrogenase deficiency specialists →